Advertisement

Gene Specific Damage and Repair of Platinum Adducts and Crosslinks

  • Vilhelm A. Bohr
  • Eddie Reed
  • Weiping Zhen

Abstract

We have developed techniques to study the DNA damage formation and repair of cisplatin lesions in individual genes. The frequency of intrastrand adducts and interstrand crosslinks can be determined in restriction fragments within genes or in non-transcribed gene regions. In hamster cells, intrastrand adducts are repaired faster from the essential dihydrofolate reductase (DHFR) gene than from an inactive region. In contrast, interstrand crosslinks are repaired at a similar rate from the active and inactive genomic regions. In an attempt to study the role of DNA repair in drug resistance, we have examined the repair of these lesions in certain important genes in cisplatin sensitive and resistant human ovarian cancer cells. The resistant cells repair interstrand crosslinks more efficiently than the sensitive ones from the DHFR gene, the multidrug resistance gene and from the inactive δglobin gene. However, these ovarian cancer cell lines do not differ in their ability to repair cisplatin intrastrand adducts from these genes.

Keywords

Ovarian Cancer Cell Line Multidrug Resistance Gene DHFR Gene Interstrand Crosslinks Preferential Repair 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bohr VA, Phillips DH, and Hanawalt PC: Editorial for “Perspectives in Cancer Research”. Cancer Res. 47: 6426–6436, 1987.PubMedGoogle Scholar
  2. 2.
    Bohr V, Smith CA, Okumoto D, and Hanawalt PC: Cell 40: 359–369, 1985.PubMedCrossRefGoogle Scholar
  3. 3.
    Bohr VA, Evans MK, and Fornace AJ Jr: Lab. Invest. 61:143–161, 1989.PubMedGoogle Scholar
  4. 4.
    Smith CA and Mellon I. In Advances in Mutagenesis Research, Ed. G. Obe, Springer Verlag, Berlin, pp153–194, 1990.CrossRefGoogle Scholar
  5. 5.
    LeDoux SP, Patton NJ, Bohr VA and Wilson GL. Journ. Biol. Chem. 265, 14875–14880, 1990.Google Scholar
  6. 6.
    Thomas DC, Morton AG, Bohr VA, and Sancar A.: Proc. Natl. Acad. Sci., USA 85: 3723–3727, 1988.PubMedCrossRefGoogle Scholar
  7. 7.
    Bohr VA and Okumoto DS. In PC Hanawalt and EC Friedberg (eds.): DNA Repair: A Manual of Research Procedures. New York: Marcel Dekker, pp. 347–366, 1988.Google Scholar
  8. 8.
    Vos J-M and Hanawalt PC: Cell 50, 789–799, 1987.PubMedCrossRefGoogle Scholar
  9. 9.
    Reed E, Sauerhoff S and Poirier MC: Atomic Spectroscopy 9, 93–95, 1988.Google Scholar
  10. 10.
    Jones JC, Zhen W, Reed E, Parker RJ, Sancar A and Bohr VA: Journ. Biol. Chem., In Press, 1991.Google Scholar
  11. 11.
    Bohr VA, Chu EHY, van Duin M, Hanawalt PC and Okumoto DS. Nucl. Acids Res. 16:7397–7403, 1988.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Vilhelm A. Bohr
    • 1
  • Eddie Reed
    • 2
  • Weiping Zhen
    • 1
  1. 1.Laboratory of Molecular PharmacologyNational Cancer InstituteBethesdaUSA
  2. 2.Laboratory of Molecular Pharmacology and Medicine BranchNational Cancer InstituteBethesdaUSA

Personalised recommendations